Overview
CJC-1295 no-DAC, often described as modified GRF(1-29), is a synthetic growth-hormone-releasing hormone analogue without a drug affinity complex. It is used as a reference material in GHRH receptor and endocrine signalling research.
Research context
The no-DAC form is commonly discussed separately from albumin-binding DAC analogues. Research contexts include GHRH receptor activity, peptide structure-function relationships, endocrine pulsatility models and comparison with growth hormone secretagogue peptides.
Analytical focus
- GHRH receptor pathway and modified GRF(1-29) literature.
- Endocrine signalling and peptide structure-function comparison.
- No-DAC identity distinction from longer-acting DAC-bound analogues.
- Sequence, salt form and purity review through the batch COA.
Batch documentation
Review the product label and the latest COA for batch-specific identity, purity, physical appearance, salt form, and analytical documentation before planning any controlled research workflow.
References and literature starting points
Research-use notice: Supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law. Not for human or animal use, consumption, diagnosis, treatment, food, supplement, cosmetic, veterinary, or similar end use.




